@inproceedings{inproceedings, title  = {{Pain analysis from the phase III randomized ALSYMPCA study with radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) with bone metastases.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2013}},

 month = {{2}},

 author = {{Nilsson S and Sartor AO and Bruland OS and Fang F and Aksnes A-K and Parker C}},

 doi = {{10.1200/jco.2013.31.6_suppl.19}},

 volume = {{31}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{6_suppl}},

 pages = {{19-19}},

 note = {{Accessed on 2025/10/10}}}